Global Continuous Renal Replacement Therapy (CRRT) Market Size By Modality (CVVH, CVVHDF, CVVHD), By Product Type (Disposables, Systems), By Geographic Scope And Forecast

Continuous Renal Replacement Therapy (CRRT) Market Size And Forecast

Continuous Renal Replacement Therapy (CRRT) Market size was valued at USD 1.17 Billion in 2021 and is projected to reach USD 2.03 Billion by 2030, growing at a CAGR of 6.3% from 2023 to 2030.

Various factors likely to boost the global Continuous Renal Replacement Therapy (CRRT) Market’s growth are the growing number of patients with AKI, the ever-increasing geriatric population with comorbidities, and the clinical advantage of CRRT over intermittent blood purification. In addition, the rise in the prevalence of diabetes and hypertension associated with acute kidney injury, government focus on providing better healthcare facilities, and increasing dialysis centers are expected to boost the global Continuous Renal Replacement Therapy (CRRT) Market.

Global Continuous Renal Replacement Therapy (CRRT) Market Definition

The CRRT industry can be traced back to the late 1970s. Burton described the term hemofiltration in 1976, and during the same year, the first multicenter trial was started to study its accuracy and effectiveness. After a year in 1977, continuous arteriovenous hemofiltration (CAVH) was introduced to treat patients suffering from acute renal failure. This technique could filter the toxins from fluids. In addition, CAVH was also able to maintain hemodynamic stability in critically ill patients.

However, it could not eliminate the nephrotoxins that turned this technique obsolete. Later, as technology progressed, in the 1990s, automated systems for CRRT were introduced in clinics and hospitals. Renal replacement therapy is used to exchange the blood-filtering function of the kidneys. In addition, it plays an essential role in treating severe acute kidney injuries and end-stage kidney diseases. Renal replacement therapy can be categorized into peritoneal dialysis, intermittent hemodialysis, and continuous renal replacement therapy.

CRRT is given to patients with acute kidney injury, particularly for hemodynamically unstable cases. CRRT involves hemodialysis, hemofiltration, or a combination of both. CRRT differs from conventional renal replacement therapies, where intermittent hemodialysis lasts for six hours. However, CRRT lasts for up to 24 hours. Removing fluid or solute at a slower rate per unit of time is the primary advantage of continuous renal replacement therapy. Therefore, continuous renal replacement therapy is primarily accepted over conventional therapies involving intermittent hydrolysis globally.

Global Continuous Renal Replacement Therapy (CRRT) Market Overview

An increase in the prevalence of acute kidney injury (AKI) is expected to increase the demand for CRRT. AKI, also known as acute renal failure (ARF), is an abrupt loss of kidney function or kidney damage within a few hours or days. AKI causes a build-up of waste products in your blood and makes it hard for your kidneys to balance the proper body fluid. AKI can also affect other organs such as the heart, brain, and lungs. Acute kidney injury is common in patients in the hospital, in intensive care units, and especially in older adults. If not treated, the condition has a high risk of multiple organ failure and death. According to the International Society of Nephrology, there are around 13.3 million cases of AKI every year.

The burden is on the increase in emerging countries, where the annual incidence is 11.3 million. Out of 1.7 million deaths per year globally caused by AKI, around 1.4 million occur in low- and middle-income countries. The increasing prevalence of AKI is strongly associated with increased early and long-term patient morbidity and mortality and chronic kidney disease (CKD). AKI is often preventable and treatable with few, if any, long-term health consequences. Identifying the signs and starting treatment early means more patients will get essential care before it is too late. The increase in the geriatric population will help the industry gain traction as older adults are more susceptible to renal failure, which is expected to drive the Continuous Renal Replacement Therapy (CRRT) Market growth.

According to United Nations, The global population aged 60 years or over was about 962 million in 2017, more than twice (382 million) as large as in 1980 globally. The number of older persons is expected to double by 2050 when projected to reach nearly 2.1 billion. In 2030, older persons are likely to outnumber children under age 10; in 2050, projections indicate that there will be more older persons aged 60 or over than adolescents and youth ages 10-24. The number of persons aged 80 years or over is projected to increase more than threefold between 2017 and 2050 Globally, rising from 137 million to 425 million. Thus, the rise in geriatric and obese people is a significant driver for global market growth.

However, the high cost associated with CRRT may restrain its demand in emerging economies, thereby hampering market growth. Markets like China, India, Brazil, and Mexico are expected to offer significant growth opportunities for players in the CRRT Market. To leverage the considerable growth opportunities in emerging countries, players increasingly focus on undertaking strategic growth to increase their presence in these markets. In addition, regulatory policies in the Asia Pacific region are more adaptive and business-friendly. This, along with the competition in the mature markets, will further encourage CRRT product manufacturers to focus on emerging markets.

Global Continuous Renal Replacement Therapy (CRRT) MarketSegmentation Analysis

The Global Continuous Renal Replacement Therapy (CRRT) Market is segmented on the basis of Modality, Product Type, and Geography.

Continuous Renal Replacement Therapy (CRRT) Market, By Modality

• Continuous venovenous hemofiltration (CVVH)
• Continuous venovenous hemodiafiltration (CVVHDF)
• Continuous venovenous hemodialysis (CVVHD)
• Slow continuous ultrafiltration (SCUF)

Based on Modality, the market is segmented into Continuous venovenous hemofiltration (CVVH), Continuous venovenous hemodiafiltration (CVVHDF), Continuous venovenous hemodialysis (CVVHD), and Slow continuous ultrafiltration (SCUF). CVVHDF is to have the highest growth rate of the CRRT Market by modality over the forecast period. The growth can be attributed to its flexibility compared to other CRRT modalities. The increasing incidence of fluid overload cases, which is frequently found in acute kidney injury patients in critical care units, would boost the growth of the CVVH sector, consequently increasing the application of CVVH treatment procedures.

Continuous Renal Replacement Therapy (CRRT) Market, By Product Type

• Dialysate & Replacement Fluids
• Disposables
• Systems
• Others

Based on Product Type, the market is segmented into Dialysate & Replacement Fluids, Disposables, Systems, and Others. Based on product type, the disposables segment is expected to dominate the global CRRT Market due to the high volume of sales of disposables and optimal bloodline sets, hemofilter, and tubing in continuous dialysis procedures. Dialysates & replacement fluid segment is expected to witness rapid growth during the forecast period. This is attributed to factors like growing demand for dialysates to remove undesired solutes and restore the electrolytes and acid-base balance, along with the presence of well-established players with robust offerings in dialysates & replacement fluid.

Continuous Renal Replacement Therapy (CRRT) Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of The World

Based on Regional Analysis, the global Continuous Renal Replacement Therapy (CRRT) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Europe dominates the market due to increased incidences of acute kidney injury and favorable reimbursement policies. In addition, the presence of key players in the region’s established research & development industry, and substantial funding from governments are driving the global market. The global CRRT Market in the Asia Pacific is expected to grow at the highest CAGR over the forecast period because of strong economic growth, improvement in healthcare infrastructure, a rise in the geriatric population, and an increase in investments in developing advanced CRRT products.

Key Players

The “Global Continuous Renal Replacement Therapy (CRRT) Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Toray Medical Co., Ltd., Infomed SA, Medtronic plc, Medica S.p.A., and Medical Components, Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In April 2020, Fresenius Medical Care received US FDA Emergency Use Authorization for multiFiltrate PRO System and multiBic/multiPlus Solutions to provide CRRT to treat patients in an acute care environment during the COVID-19 pandemic.
• In August 2020, Baxter obtained US FDA Emergency Use Authorization for Regiocit Replacement Solution used In CRRT.
• In December 2020, Medtronic Plc announced the launch of a new Carpedium system. This system was the first neonatal and pediatric acute dialysis system created for treating patients who need renal replacement therapy.
• In January 2019, The 4008A dialysis machine was launched in India by Fresenius Medical Care AG&Co.KGaA.
• In April 2020, Baxter International Inc. announced that the company had increased its critically-needed dialysis products worldwide. The company is collaborating with governments around the world to help assist with these challenges.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Continuous Renal Replacement Therapy (CRRT) Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.